Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

NuChem Therapeutics

NuChem Therapeutics
2011 FOUNDED
PRIVATE STATUS
Buyout/LBO LATEST DEAL TYPE
6 INVESTORS
Description

Provider of medicinal chemistry contract research services intended to identify and optimize pre-clinical candidates in the area of small molecule drug discovery. The company's research includes specialization in the art of medicinal chemistry, drug discovery biology and can provide custom synthesis of compounds, structure-activity-relationship design, DMPK services, computational drug design, enabling companies to identify, optimize and produce candidate molecules to become drugs.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Pharmaceuticals
Primary Office
  • 6100 Royalmount Avenue
  • Montreal, Quebec H4P 2R2
  • Canada

+1 (514) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore NuChem Therapeutics’s full profile, request a free trial.

NuChem Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Buyout/LBO 22-Feb-2019 Completed Generating Revenue
1. Seed Round 03-Apr-2012 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

NuChem Therapeutics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Fonds de solidarité FTQ PE/Buyout Minority 000 0000 000000 0
Investissement Québec Venture Capital Minority 000 0000 000000 0
GeneChem Venture Capital Minority 000 0000 000000 0
Institut De Recherche Clinique De Montreal Corporation Minority 000 0000 000000 0
Nabil Seidah Corporation Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

NuChem Therapeutics Executive Team (3)

Name Title Board
Seat
Contact
Info
Marc LeBel Board Member & President
Daniel Guay Ph.D Executive Director & Chief Scientific Officer
Lyne Routhier Director of Finance

NuChem Therapeutics Board Members (4)

Name Representing Role Since Contact
Info
Inès Holzbaur Ph.D GeneChem Chairman 000 0000
John Gillard Ph.D Self Board Member 000 0000
Louis Lacasse GeneChem Board Member 000 0000
Marc LeBel NuChem Therapeutics Board Member & President 000 0000